Table 1.
Baseline Parameters, Demographics, and Treatment.
| Parameter | Control (n = 37) | Intervention (n = 38) | P a |
|---|---|---|---|
| Age, mean (SD) | 53 (12) | 51 (12) | .44 |
| Sex, number female (%) | 12 (32%) | 19 (50%) | .12 |
| Diabetes medications, number (%)b | .07 | ||
| 0 | 6 (16%) | 2 (5%) | |
| 1 | 7 (19%) | 16 (42%) | |
| 2 | 20 (54%) | 14 (37%) | |
| 3 | 4 (11%) | 6 (16%) | |
| Taking Insulin, number (%) | 10 (27%) | 15 (39%) | .25 |
| SBP (mm Hg) | 125 (12) | 123 (15) | .31 |
| DBP (mm Hg) | 73 (7) | 72 (10) | .49 |
| BMI (kg/m2) | 33 (7) | 35 (10) | .22 |
| WC (cm) | 41 (7) | 43 (6) | .053 |
| A1c (%) | 8.9 (1.3) | 9.2 (1.9) | .69 |
| TChol (mg/dL) | 176 (43) | 166 (30) | .42 |
| TG (mg/dL) | 182 (154) | 181 (111) | .44 |
| HDL (mg/dL) | 46 (13) | 44 (11) | .95 |
| LDL (mg/dL) | 125 (12) | 123 (15) | .31 |
| Lost to follow-up | 11 (30%) | 15 (39%) | .38 |
BMI, body mass index; DBP, diastolic blood pressure; HbA1c, hemoglobin a1c percentage; HDL, high density lipoprotein; LDL, low density lipoprotein; NR, not reported; SBP, systolic blood pressure.
a
For sex, number of diabetes medications, number on insulin, and lost to follow-up, by chi-square test; for all others, by rank sum test.
b
Oral hypoglycemics not including insulin.